Facts About azelaprag peptide Revealed
Azelaprag was nicely tolerated With this review and in the least doses analyzed thus far in 227 subjects, with a security profile in keeping with the results of prior phase 1 trials executed by Amgen.Apelin receptor agonists are now being pursued for his or her clinical inotropic opportunity in the therapy of heart failure. (Sourced from: )In the l